Latest News for: Vtv

Edit

vTv Therapeutics and M42’s IROS Announce Submission of Phase 2 Clinical Study Protocol for Cadisegliatin ...

Nasdaq Globe Newswire 18 Dec 2025
Trial to assess cadisegliatin as potential adjunctive therapy to insulin in patients with T2D. Trial to assess cadisegliatin as potential adjunctive therapy to insulin in patients with T2D ... .
Edit

ABC-Australia signs MoU with VTV-Vietnam for broadcasting partnership (ABU - Asia-Pacific Broadcasting Union)

Public Technologies 16 Dec 2025
). The text version of this document is not available ... Attachments Original document Permalink.
Edit

ABC signs MoU with VTV for broadcasting partnership (ABU - Asia-Pacific Broadcasting Union)

Public Technologies 15 Dec 2025
). The text version of this document is not available ... Attachments Original document Permalink.
Edit

Welcome to the updated VTV.fi site (National Audit Office of Finland)

Public Technologies 10 Dec 2025
) Frontpage What's new Article 10.12.2025 at 10.33 Article The new VTV.fi website was launched on 25 November 2025 ...
Edit

Notice of Effectiveness (Form EFFECT) (vTv Therapeutics Inc)

Public Technologies 25 Nov 2025
) UNITED STATES. SECURITIES AND EXCHANGE COMMISSION. Washington, D.C. 20549 ... vTv Therapeutics Inc ... vTv Therapeutics Inc.
Edit

2019 Q2 Earnings Release (vTv Therapeutics Inc)

Public Technologies 21 Nov 2025
). The text version of this document is not available ... vTv Therapeutics Inc.
Edit

VTv Therapeutics: Q3 Earnings Snapshot

Daily Advance 07 Nov 2025
HIGH POINT, N.C. (AP) — HIGH POINT, N.C. (AP) — VTv Therapeutics Inc. (VTVT) on Thursday reported a loss of $8.7 million in its third quarter ... .
Edit

vTv Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update

Nasdaq Globe Newswire 06 Nov 2025
Topline Phase 3 CATT1 data for cadisegliatin in type 1 diabetes expected second half 2026� ... .
Edit

vTv Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update (Form 8-K) (vTv Therapeutics Inc)

Public Technologies 06 Nov 2025
) vTv Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update ... HIGH POINT, N.C., November 6, 2025 (GLOBE NEWSWIRE) - vTv Therapeutics Inc ... vTv Therapeutics Inc ... vTv Therapeutics Inc ... About vTv Therapeutics.
Edit

vTv Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update (vTv Therapeutics Inc)

Public Technologies 06 Nov 2025
06, 2025 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc ... "The third quarter saw a series of meaningful achievements," said Paul Sekhri, Chairman, President and CEO of vTv Therapeutics ... vTv Therapeutics Inc ... vTv Therapeutics Inc ... vTv Therapeutics Inc.
Edit

Quarterly Report for Quarter Ending September 30, 2025 (Form 10-Q) (vTv Therapeutics Inc)

Public Technologies 06 Nov 2025
vTv Therapeutics Inc. is a holding company and its principal asset is a controlling equity interest in vTv Therapeutics LLC ("vTv LLC"), the principal operating subsidiary ... vTv Therapeutics Inc ... Net loss attributable to vTv Therapeutics Inc.
Edit

Ngọc named most successful player of VTV A.O SMITH Pickleball Open

Vietnam News 27 Oct 2025
Sĩ Bội Ngọc scored a double title in the VTV A.O SMITH Pickleball Open 2025, which ended on October 26 in Hà Nội ... HÀ NỘI — Sĩ Bội Ngọc scored a double title in the VTV A.O SMITH ...
Edit

vTv Therapeutics Announces New Appointments to its Scientific Advisory Board

Nasdaq Globe Newswire 09 Oct 2025
Board to offer guidance on clinical development of cadisegliatin for type 1 diabetes as company has initiated Phase 3 trials ... .
Edit

'VTV' duo reunites: THIS actress to play opposite Silambarasan in 'Arasan'; shoot to begin soon

The Times of India 07 Oct 2025
The long-awaited Silambarasan and Vetri Maaran collaboration in Tamil cinema has officially come to completion. The film, which was originally called ‘STR 49,’ has now been titled ‘Arasan,’ and the makers have officially unveiled the film's title ... .
Edit

Registration Statement - Specified Transactions (Form S-3) (vTv Therapeutics Inc)

Public Technologies 03 Oct 2025
The outstanding shares of our Class A common stock offered hereby were issued either (w) pursuant to certain letter agreements between us and MacAndrews & Forbes Group LLC, (x) to the holders ...

Article Search

tools
×
×
×
×